Arizona State Retirement System Cel Sci Corp Transaction History

Arizona State Retirement System

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$2.58 - $4.99 $30,007 - $58,038	-11,631 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$3.93 - $7.7 $196 - $385	50 Added 0.43%	11,631 $46,000
Q4 2021 Feb 04, 2022	BUY	$7.1 - $12.82 $3,109 - $5,615	438 Added 3.93%	11,581 $82,000
Q3 2021 Nov 12, 2021	BUY	$7.64 - $12.49 $962 - $1,573	126 Added 1.14%	11,143 $122,000
Q2 2021 Aug 02, 2021	BUY	$8.68 - $27.49 $2,916 - $9,236	336 Added 3.15%	11,017 $96,000
Q1 2021 May 06, 2021	BUY	$12.0 - $27.64 $480 - $1,105	40 Added 0.38%	10,681 $162,000
Q4 2020 Jan 28, 2021	SELL	$11.05 - $16.62 $1,613 - $2,426	-146 Reduced 1.35%	10,641 $124,000
Q3 2020 Nov 05, 2020	BUY	$11.69 - $14.54 $126,100 - $156,842	10,787 New	10,787 $138,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $28.2M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.